Women's Health
Context Therapeutics Reports 29% Response Rate in PROC Phase 1 Trial
Interim RECIST v1.1 data from Context Therapeutics positions CTIM-76 as a clinical-stage candidate in a heavily pre-tre…
Women's Health 7 stories
Women's Health
Nucleus Genomics Expands IVF+ Network to Hawaii and Asia-Pacific
The network expansion signals growing operator demand for genomic optimization tools at the clinical fertility interfac…
Women's Health
Nucleus IVF+ Network Adds Hawaii Clinic Amid Embryo Genomics Demand
The partnership signals growing operator interest in genomics-adjacent reproductive health services as precision nutrit…
Women's Health
Nucleus IVF+ Network Expands to Hawaii Amid Genetic Testing Demand
The partnership signals growing operator demand for genetic optimization services within assisted reproduction — a cate…
Women's Health
PRM and Project Endo Target Campus Health with Endo Screening Push
An estimated 1 in 10 women of reproductive age live with endometriosis — a condition averaging a 7–10 year diagnostic d…
Women's Health
Chronic Pain Research Gap in Women Signals Formulation Opportunity
Pan-Canadian strategy roadmap identifies research and care gaps — opening a lane for evidence-backed nutraceutical and …
Women's Health
Chronic Pain Gap in Women and Veterans Signals Formulation Opportunity
Pan-Canadian strategy roadmap identifies research, care, and policy gaps — opening space for evidence-backed nutraceuti…